Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Inhibition of Aldose Reductase and Sorbitol Accumulation by Hydroalcoholic Extract of Propolis

Mohammad Aberomand 1 , Maliheh Parvank 1 , Ghorban Mohammadzadeh 2 , * and Zahra Ramezani 3
Authors Information
1 Toxicology Research Center, Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Hyperlipidemia Research Center, Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Toxicology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 01, 2016, 11 (1); e24594
  • Published Online: February 20, 2016
  • Article Type: Research Article
  • Received: October 18, 2014
  • Revised: May 10, 2015
  • Accepted: May 20, 2015
  • DOI: 10.17795/jjnpp-24594

To Cite: Aberomand M, Parvank M, Mohammadzadeh G, Ramezani Z. Inhibition of Aldose Reductase and Sorbitol Accumulation by Hydroalcoholic Extract of Propolis, Jundishapur J Nat Pharm Prod. 2016 ; 11(1):e24594. doi: 10.17795/jjnpp-24594.

Abstract
Copyright © 2016, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Cumbie BC, Hermayer KL. Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications. Vasc Health Risk Manag. 2007; 3(6): 823-32[PubMed]
  • 2. Gabbay KH. The sorbitol pathway and the complications of diabetes. N Engl J Med. 1973; 288(16): 831-6[DOI][PubMed]
  • 3. Oates PJ. Polyol pathway and diabetic peripheral neuropathy. 2002; 50: 325-92[DOI]
  • 4. Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res. 2007; 2007: 61038[DOI][PubMed]
  • 5. Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes. 2004; 53(9): 2404-11[PubMed]
  • 6. Barnett PA, Gonzalez RG, Chylack LJ, Cheng HM. The effect of oxidation on sorbitol pathway kinetics. Diabetes. 1986; 35(4): 426-32[PubMed]
  • 7. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993; 42(6): 801-13[PubMed]
  • 8. Crabbe MJ. Aldose reductase inhibitors and cataract. Int Ophthalmol. 1991; 15(1): 25-36[PubMed]
  • 9. Hayman S, Kinoshita JH. Isolation and Properties of Lens Aldose Reductase. J Biol Chem. 1965; 240: 877-82[PubMed]
  • 10. Varma S, Mizuno A, Kinoshita J. Diabetic cataracts and flavonoids. Science. 1977; 195(4274): 205-6[DOI]
  • 11. Van Zandt MC, Sibley EO, McCann EE, Combs KJ, Flam B, Sawicki DR, et al. Design and synthesis of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complications. Bioorg Med Chem. 2004; 12(21): 5661-75
  • 12. Tomlinson DR, Stevens EJ, Diemel LT. Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol Sci. 1994; 15(8): 293-7[DOI]
  • 13. Kim JK, Lee YS, Kim SH, Bae YS, Lim SS. Inhibition of aldose reductase by phenylethanoid glycoside isolated from the seeds of Paulownia coreana. Biol Pharm Bull. 2011; 34(1): 160-3[PubMed]
  • 14. Raskin P, Rosenstock J. Aldose reductase inhibitors and diabetic complications. Am.J Med. 1987; 83(2): 298-306[DOI]
  • 15. Pfeifer MA, Schumer MP, Gelber DA. Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes. 1997; 46 Suppl 2-9[PubMed]
  • 16. Saab N. Phenylsulfonylnitromethanes as potent irreversible inhibitors of aldose reductase. European Journal of Medicinal Chemistry. 1999; 34(9): 745-51[DOI]
  • 17. Lim SS, Jung SH, Ji J, Shin KH, Keum SR. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. J Pharm Pharmacol. 2001; 53(5): 653-68[PubMed]
  • 18. Lee YS, Lee S, Lee HS, Kim BK, Ohuchi K, Shin KH. Inhibitory effects of isorhamnetin-3-O-beta-D-glucoside from Salicornia herbacea on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. Biol Pharm Bull. 2005; 28(5): 916-8[PubMed]
  • 19. Richeti F, Noronha RM, Waetge RT, de Vasconcellos JP, de Souza OF, Kneipp B, et al. Evaluation of AC(n) and C(-106)T polymorphisms of the aldose reductase gene in Brazilian patients with DM1 and susceptibility to diabetic retinopathy. Mol Vis. 2007; 13: 740-5[PubMed]
  • 20. Abhary S, Burdon KP, Laurie KJ, Thorpe S, Landers J, Goold L, et al. Aldose reductase gene polymorphisms and diabetic retinopathy susceptibility. Diabetes Care. 2010; 33(8): 1834-6[DOI][PubMed]
  • 21. Bhatnagar A, Srivastava SK. Aldose reductase: Congenial and injurious profiles of an enigmatic enzyme. Biochem Med Metab Biol. 1992; 48(2): 91-121[DOI]
  • 22. Kador PF, Robison WJ, Kinoshita JH. The pharmacology of aldose reductase inhibitors. Annu Rev Pharmacol Toxicol. 1985; 25: 691-714[DOI][PubMed]
  • 23. El-Kabbani O, Carbone V, Darmanin C, Oka M, Mitschler A, Podjarny A, et al. Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity. J Med Chem. 2005; 48(17): 5536-42[DOI][PubMed]
  • 24. Srivastava SK, Petrash JM, Sadana IJ, Ansari NH, Partridge CA. Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors. Curr Eye Res. 1982; 2(6): 407-10[PubMed]
  • 25. Spite M, Baba SP, Ahmed Y, Barski OA, Nijhawan K, Petrash JM, et al. Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. Biochem J. 2007; 405(1): 95-105[DOI][PubMed]
  • 26. Zia M, Mannani R, Mahmoodi M, Bayat M, Mohaghegh F. The effects of alcoholic extract of propolis obtained from Iran bee hives on the growth of Trichophyton mentagrophytis, Trichophyton rubrum and Trichophyton verrucosum. J Isfahan Med.Sch. 2009; 27(95): 232-41
  • 27. Sonmez S, Kirilmaz L, Yucesoy M, Yucel B, Yilmaz B. The effect of bee propolis on oral pathogens and human gingival fibroblasts. J Ethnopharmacol. 2005; 102(3): 371-6[DOI][PubMed]
  • 28. Kolankaya D, Selmanoglu G, Sorkun K, Salih B. Protective effects of Turkish propolis on alcohol-induced serum lipid changes and liver injury in male rats. Food Chemistry. 2002; 78(2): 213-7[DOI]
  • 29. Talas ZS, Gulhan MF. Effects of various propolis concentrations on biochemical and hematological parameters of rainbow trout (Oncorhynchus mykiss). Ecotoxicol Environ Saf. 2009; 72(7): 1994-8[DOI][PubMed]
  • 30. Bankova V. Chemical diversity of propolis and the problem of standardization. J Ethnopharmacol. 2005; 100(1-2): 114-7[DOI][PubMed]
  • 31. Mohammadzadeh S, Sharriatpanahi M, Hamedi M, Amanzadeh Y, Sadat Ebrahimi SE, Ostad SN. Antioxidant power of Iranian propolis extract. Food Chemistry. 2007; 103(3): 729-33[DOI]
  • 32. Tavares DC, Mazzaron Barcelos GR, Silva LF, Chacon Tonin CC, Bastos JK. Propolis-induced genotoxicity and antigenotoxicity in Chinese hamster ovary cells. Toxicol In Vitro. 2006; 20(7): 1154-8[DOI][PubMed]
  • 33. Aljadi AM, Kamaruddin MY. Evaluation of the phenolic contents and antioxidant capacities of two Malaysian floral honeys. Food Chemistry. 2004; 85(4): 513-8[DOI]
  • 34. Meda A, Lamien C, Romito M, Millogo J, Nacoulma OG. Determination of the total phenolic, flavonoid and proline contents in Burkina Fasan honey, as well as their radical scavenging activity. Food Chemistry. 2005; 91(3): 571-7[DOI]
  • 35. Buratti S, Benedetti S, Cosio MS. Evaluation of the antioxidant power of honey, propolis and royal jelly by amperometric flow injection analysis. Talanta. 2007; 71(3): 1387-92[DOI][PubMed]
  • 36. Suryanarayana P, Kumar PA, Saraswat M, Petrash JM, Reddy GB. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. Mol Vis. 2004; 10: 148-54[PubMed]
  • 37. Crosas B, Hyndman DJ, Gallego O, Martras S, Pares X, Flynn TG, et al. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem J. 2003; 373: 973-9[DOI][PubMed]
  • 38. Morrison AD, Clements RJ, Winegrad AI. Effects of elevated glucose concentrations on the metabolism of the aortic wall. J Clin Invest. 1972; 51(12): 3114-23[DOI][PubMed]
  • 39. Reddy GB, Satyanarayana A, Balakrishna N, Ayyagari R, Padma M, Viswanath K, et al. Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy. Mol Vis. 2008; 14: 593-601[PubMed]
  • 40. Reddy GB, Muthenna P, Akileshwari C, Saraswat M, Petrash JM. Inhibition of aldose reductase and sorbitol accumulation by dietary rutin. Current Science. 2011; 101(9): 1191-7
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments